School of Medicine Publications
Document Type
Article
Publication Date
11-21-2025
Abstract
Mpox, a zoonotic viral disease, has emerged as a global concern due to outbreaks in both endemic and non-endemic regions in 2022. Rodents, including African squirrels and Gambian pouched rats, are suspected key reservoirs, with human infections occurring through direct contact with infected animals or bushmeat consumption. Previously confined to rural Africa, mpox has spread via international travel and the exotic pet trade. Human-to-human transmission occurs mainly via respiratory droplets and direct contact with bodily fluids or lesions. The virus has a double-stranded DNA genome within a lipid envelope. Despite lower mutation rates in DNA viruses, mpox has developed mutations, particularly in genes like F8L, G9R, and F13L, facilitating viral replication and immune evasion. The virus targets immune cells such as monocytes and macrophages, weakening host defenses and prolonging infection. Immunocompromised individuals are at higher risk of severe complications. Although generally self-limiting, severe cases may require antiviral treatment. This article briefly summarizes the therapeutic and preventive strategies, and public health measures to combat zoonotic threats.
Recommended Citation
Zaman, M. S., Sizemore, R. C., Rodriguez, D., Lopez, E., Alam, S. M. G., Tufa, S., Lopez-Alvarenga, J. C., Akimbekov, N. S., & Razzaque, M. S. (2025). Mpox Insights: From Structure to Human Cell Interaction. Journal of Molecular Pathology, 6(4), 29. https://doi.org/10.3390/jmp6040029
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Publication Title
Journal of Molecular Pathology
DOI
10.3390/jmp6040029
Academic Level
faculty
Mentor/PI Department
Medical Education

Comments
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).